V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20138608 | 20157879 | 1.82 | 73 | Curative (C) | 2017-05-24 | 2017-10-17 | CAV | 02 | Y | SCOPE2 TRIAL | 100027479 |
| 20139650 | 20157880 | 1.77 | 112.45 | null | 2019-04-15 | 2019-04-15 | Doxorubicin + Steptozotocin | 02 | N | ALEMTUZUMAB | 101453516 |
| 20139686 | 20157881 | 1.79 | 60.8 | 03 | 2015-06-02 | 2016-09-04 | null | 02 | N | IXAZOMIB + LENALIDOMIDE | 100253851 |
| 20139972 | 20157882 | 1.72 | 89.5 | Palliative (P) | 2019-12-11 | 2019-12-11 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + Pertuzumab + Trastuzumab | 02 | N | CARBOPLATIN + PEMETREXED | 101249641 |
| 20141452 | 20157883 | 1.77 | 76 | null | 2018-04-08 | 2018-04-08 | CYCLOPHOSPHAMIDE | 02 | Y | CARFILZOMIB | 100507400 |
| 20141651 | 20157884 | 1.85 | 86.3 | null | 2017-04-25 | 2017-05-10 | CAPECITABINE + MITOMYCIN + RT | 02 | null | IBRUTINIB | 100425644 |
| 20141745 | 20157885 | 1.57 | 67.4 | Palliative (P) | 2019-08-23 | 2019-11-14 | Temozolomide 150mg/m2 | 02 | N | CAPECITABINE + TRASTUZUMAB | 101465889 |
| 20142414 | 20157888 | 1.65 | 113 | null | null | 2020-05-30 | IBRUTINIB | 02 | N | TRIPLE INTRATHECAL | 100521092 |
| 20142471 | 20157889 | 1.8 | 44 | Palliative (P) | 2016-05-02 | 2017-03-07 | PERTUZUMAB + TRASTUZUMAB | 02 | null | INTERAACT TRIAL | 100134933 |
| 20142578 | 20157890 | 1.65 | 51.4 | Adjuvant (A) | 2017-12-09 | 2017-12-09 | Cisplatin + Pemetrexed | 02 | null | RUCAPARIB | 100943522 |
| 20142915 | 20157891 | 1.72 | 61.9 | Palliative (P) | 2015-06-29 | 2018-07-14 | Cyclophos + Dex + Lenalidomide | 02 | N | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 100097838 |
| 20143244 | 20157892 | null | 76.5 | Curative (C) | 2018-09-23 | 2018-12-28 | Temozolomide + RT | N | N | PERTUZUMAB + TRASTUZUMAB | 100190619 |
| 20143370 | 20157893 | 1.53 | 44.9 | Curative (C) | 2016-11-17 | 2016-12-05 | Bevacizumab + Oxaliplatin +MdG | 02 | N | CAP + RT | 100028118 |
| 20143492 | 20157895 | 1.82 | 80 | Palliative (P) | 2020-03-16 | 2020-06-10 | CISPLATIN + RALTITREXED | 02 | N | CAPECITABINE + CETUXIMAB + OXALIPATIN | 100834785 |
| 20143702 | 20157896 | 1.84 | 82.6 | Palliative (P) | 2018-01-19 | 2018-02-05 | ETOPOSIDE | 02 | null | PEMBROLIZUMAB + PEMETREXED | 100482860 |
| 20143988 | 20157898 | 1.78 | 102.4 | Palliative (P) | 2019-09-20 | 2019-09-21 | Trabectedin | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101187221 |
| 20144687 | 20157899 | 1.8 | 70.2 | Palliative (P) | 2017-06-28 | 2017-07-13 | FLUOROURACIL + Liposomal irinotecan | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100262936 |
| 20144867 | 20157900 | 1.83 | 95 | null | 2019-05-02 | 2019-05-03 | null | 02 | N | NINTEDANIB | 100413733 |
| 20145424 | 20157901 | 1.53 | 70.1 | Palliative (P) | 2020-01-05 | 2020-01-05 | DA 3 + 10 | 02 | null | EOF | 101806526 |
| 20146362 | 20157902 | 1.69 | 79 | null | 2021-03-06 | 2021-03-06 | Bortezomib + Cyclophos + Dex | 02 | null | CARBOPLATIN + FLUOROURACIL + TRASTUZUMAB | 100714816 |
| 20146423 | 20157903 | 1.82 | 74.6 | null | 2019-03-28 | 2019-04-22 | Bevacizumab + Cape + Irino 21day | 02 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101120411 |
| 20146817 | 20157904 | 1.54 | 80 | Neo-adjuvant (N) | 2020-12-20 | 2021-11-29 | Bevacizumab + Irinotecan + MdG | 02 | N | SCOPE2 TRIAL | 101014132 |
| 20147170 | 20157905 | 1.56 | 94 | null | 2020-03-08 | 2020-03-20 | CARBOPLATIN + GEMCITABINE | 02 | N | CAP + RT | 101789225 |
| 20147197 | 20157906 | 1.61 | 62.6 | Disease modification (D) | 2021-12-07 | 2021-12-16 | ECF | 02 | N | BACILLUS CALMETTE-GUERIN | 100843358 |
| 20147238 | 20157907 | 1.32 | 63.2 | null | 2019-11-16 | 2019-11-16 | AFATINIB | 02 | null | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 100388128 |
| 20147403 | 20157908 | null | null | Curative (C) | 2016-12-17 | 2017-03-18 | Bortezomib +/- Dexamethasone | 02 | N | ETOPOSIDE | 100772465 |
| 20148059 | 20157910 | 1.65 | 0 | Curative (C) | 2020-02-17 | 2020-04-07 | Pemigatinib | 02 | N | IPILIMUMAB | 100347012 |
| 20148182 | 20157911 | 1.89 | 67.5 | null | 2019-01-03 | 2019-01-03 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | TRASTUZUMAB + VINORELBINE | 101627462 |
| 20148325 | 20157912 | 1.8 | 46.5 | null | 2021-12-25 | 2022-02-17 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | RITUXIMAB | 101071880 |
| 20148558 | 20157913 | 1.56 | 126 | Curative (C) | 2019-12-03 | 2019-12-06 | BORTEZOMIB + DARATUMUMAB + THALIDOMIDE | 02 | N | BACILLUS CALMETTE-GUERIN | 101213518 |
| 20149019 | 20157914 | 1.57 | 78.8 | 03 | 2019-11-15 | 2019-11-22 | Cabazitaxel | 02 | N | AFATINIB | 101631269 |
| 20149178 | 20157915 | null | 66.5 | null | 2020-07-24 | 2020-09-07 | Carboplatin + Pemetrexed | 02 | N | MITOMYCIN | 101299694 |
| 20149286 | 20157916 | 1.84 | 74.4 | Curative (C) | 2021-01-31 | 2021-01-31 | COSMIC TRIAL | 02 | null | BEVACIZUMAB + CAPECITABINE + IRINOTECAN | 101393517 |
| 20149311 | 20157917 | 1.9 | 116 | null | 2018-06-20 | 2018-07-03 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | ECARBOF | 101059622 |
| 20149423 | 20157918 | 1.81 | 94.6 | Adjuvant (A) | 2019-08-28 | 2019-08-28 | DARATUMUMAB | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101183253 |
| 20149597 | 20157919 | 1.57 | 75.8 | null | 2018-08-06 | 2018-08-06 | Cisplatin +FU +Trastuzumab - Maint | 02 | null | FOXTROT TRIAL | 101611825 |
| 20149655 | 20157920 | 1.71 | 52 | Palliative (P) | 2018-02-19 | 2018-03-30 | Eribulin | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100089119 |
| 20149841 | 20157921 | 1.75 | 82.3 | null | 2018-08-06 | 2018-11-25 | SCOPE 2 TRIAL | 02 | null | ARISTOTLE TRIAL | 100178999 |
| 20150028 | 20157922 | null | null | Curative (C) | 2018-01-14 | 2018-01-14 | VINORELBINE | null | null | HEPATOBLASTOMA SR CISPLATIN | 100847809 |
| 20150859 | 20157924 | 1.57 | 0 | null | null | 2021-07-19 | null | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101533733 |
| 20150915 | 20157925 | 1.69 | 59.9 | Palliative (P) | 2019-10-23 | 2020-01-19 | Carboplatin + Pemetrexed | 02 | N | BORTEZOMIB + PANOBINOSTAT | 101319846 |
| 20151823 | 20157927 | 1.5 | 66 | Neo-adjuvant (N) | 2019-09-21 | 2019-11-23 | COSMIC TRIAL | 02 | null | CISPLATIN + TEYSUNO | 100679599 |
| 20151919 | 20157928 | 1.6 | 120.2 | Palliative (P) | 2018-12-09 | 2018-12-10 | MIC | 01 | null | HYDROXYCARBAMIDE | 100567508 |
| 20152027 | 20157929 | 1.74 | 76 | null | 2015-08-14 | 2018-04-23 | Cisplatin + Pemetrexed | null | N | GEMCITABINE + PACLITAXEL | 100420980 |
| 20152042 | 20157930 | 1.7 | 77 | Palliative (P) | 2018-03-23 | 2018-04-03 | SCOPE 2 TRIAL | 02 | N | RITUXIMAB | 100555245 |
| 20152086 | 20157931 | 1.82 | null | 03 | 2021-02-19 | 2021-02-20 | CISPLATIN + RALTITREXED | N | null | BENDAMUSTINE + THALIDOMIDE | 100729830 |
| 20152813 | 20157932 | null | null | Palliative (P) | 2022-02-26 | 2022-03-05 | IBRUTINIB | 02 | N | GEMCITABINE + RT | 100598057 |
| 20153102 | 20157933 | 1.71 | 55.1 | Curative (C) | 2018-02-04 | 2018-02-22 | SCOPE 2 TRIAL | 02 | Y | NILOTINIB | 100467017 |
| 20153311 | 20157934 | 1.69 | 87.7 | Palliative (P) | 2018-08-14 | 2018-08-30 | Azacitidine | 02 | null | CISPLATIN + TEYSUNO | 101013364 |
| 20153459 | 20157935 | 1.56 | null | Palliative (P) | 2019-12-22 | 2019-12-24 | Bevacizumab + CAPECITABINE + IRINOTECAN | 02 | null | IRINOTECAN + MDG + PANITUMUMAB | 100691069 |